PERI-OPERATIVE ORTHOPEDIC MANAGEMENT OF A PATIENT WITH SEVERE HEMOPHILIA A AND A FACTOR VIII INHIBITOR ON EMICIZUMAB

被引：0
|
作者：
Rupani, Natasha S. [1 ]
Khalife, Roy [2 ]
Tinmouth, Alan [2 ]
Ward, Sarah [3 ]
Sholzberg, Michelle [4 ,5 ]
Teitel, Jerry [4 ]
机构：
[1] Univ Toronto, Div Hematol, Dept Med, Toronto, ON, Canada
[2] Univ Ottawa, Div Hematol, Dept Med, Ottawa Hosp, Ottawa, ON, Canada
[3] Univ Toronto, St Michaels Hosp, Div Orthopaed Surg, Dept Surg, Toronto, ON, Canada
[4] Univ Toronto, St Michaels Hosp, Div Hematol, Dept Med, Toronto, ON, Canada
[5] Univ Toronto, St Michaels Hosp, Div Hematol, Dept Lab Med & Pathobiol, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E93 / E93
页数：1
相关论文
共 50 条
  • [1] Peri-operative management of frailty in the orthopedic patient
    Mamtora, Pragati H.
    Fortier, Michelle A.
    Barnett, Sheila R.
    Schmid, Lauren N.
    Kain, Zeev N.
    JOURNAL OF ORTHOPAEDICS, 2020, 22 : 304 - 307
  • [2] Hemodialysis in a patient with severe hemophilia A and factor VIII inhibitor
    Gopalakrishnan, Natarajan
    Usha, Thiruvengadam
    Thopalan, Balasubramaniyan
    Dhanapriya, Jeyachandran
    Dineshkumar, Thanigachalam
    Thirumalvalavan, Kaliaperumal
    Sakthirajan, Ramanathan
    HEMODIALYSIS INTERNATIONAL, 2016, 20 (04) : E11 - E13
  • [3] Peri-operative management in inhibitor patients
    Negrier, C.
    HAEMOPHILIA, 2008, 14 (02) : 400 - 400
  • [4] Peri-operative hemostatic management of tooth extraction in patients with hemophilia A, with and without inhibitors, receiving emicizumab prophylaxis
    Yagyuu, Takahiro
    Furukawa, Shoko
    Zaizen, Miki
    Yata, Sachiko
    Imada, Mitsuhiko
    Nogami, Keiji
    Kirita, Tadaaki
    HAEMOPHILIA, 2023, 29 (01) : 172 - 179
  • [5] Variations in international practices for the peri-operative management of major surgery for persons with severe hemophilia
    Holme, P.
    James, P.
    Gomez, K.
    Fogarty, P.
    HAEMOPHILIA, 2010, 16 : 23 - 23
  • [6] PERI-OPERATIVE MANAGEMENT OF SEVERE THYROTOXICOSIS WITH ESMOLOL
    VIJAYAKUMAR, HR
    THOMAS, WO
    FERRARA, JJ
    ANAESTHESIA, 1989, 44 (05) : 406 - 408
  • [7] Emicizumab for hemophilia A with factor VIII inhibitors
    Young, Guy
    Callaghan, Michael
    Dunn, Amy
    Kruse-Jarres, Rebecca
    Pipe, Steven
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (11) : 835 - 846
  • [8] Additional use of Factor VIII to a Patient with Severe Hemophilia a Receiving Emicizumab Prophylaxis from Infancy
    Yagi, Takeshi
    Matsuda, Takehiro
    Inamine, Itsuki
    Higa, Takeshi
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [9] Peri-operative management of frailty in the orthopedic patient (vol 22, pg 304, 2020)
    Mamtora, Pragati H.
    Fortier, Michelle A.
    Barnett, Sheila R.
    Schmid, Lauren N.
    Kain, Zeev N.
    JOURNAL OF ORTHOPAEDICS, 2021, 23 : 274 - 274
  • [10] NOVEL APPROACH FOR IMMUNOSUPPRESSION AND PERI-OPERATIVE RECOMBINANT PORCINE FACTOR VIII REPLACEMENT FOR PEDIATRIC CONGENITAL HEMOPHILIA A WITH HIGH-TITER INHIBITOR
    Abajas, Yasmina L.
    Monahan, Paul E.
    Neufeld, Ellis J.
    Nielsen, Brenda
    Rollins-Raval, Marian
    Wolberg, Alisa
    Croteau, Stacy E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E416 - E416
12345